Tracy Batchelor

  • Latest publications

    Gerstner ER, Ye X, Duda DG, Levine MA, Mikkelsen T, Kaley TJ, Olson JJ, Nabors BL, Ahluwalia MS, Wen PY, Jain RK, Batchelor TT, Grossman S. A phase I study of cediranib in combination with cilengitide in patients with recurrent glioblastoma. Neuroncol. 2015.

    Lee EQ, Kaley TJ, Duda DG, Schiff D, Lassman AB, Wong ET, Mikkelsen T, Purow BW, Muzikansky A, Ancukiewicz M, Huse JT, Ramkissoon S, Drappatz J, Norden AD, Beroukhim R, Weiss SE, Alexander BM, McCluskey CS, Gerard M, Smith KH, Jain RK, Batchelor TT, Ligon KL, Wen PY. A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients. Clin Cancer Res 2015.

    Betensky RA, Szymonifka J, Lee EQ, Nutt CL, Batchelor TT. Computationally simple analysis of matched, outcome-based studies of ordinal disease states. Stat Med 2015; 34:2514-27.

    Neagu MR, Gill CM, Batchelor TT, Brastianos PK. Genomic profiling of brain metastases: current knowledge and new frontiers. Chin Clin Oncol 2015; 4:22.

    Jafari-Khouzani K, Emblem KE, Kalpathy-Cramer J, Bjørnerud A, Vangel MG, Gerstner ER, Schmainda KM, Paynabar K, Wu O, Wen PY, Batchelor T, Rosen B, Stufflebeam SM. Repeatability of Cerebral Perfusion Using Dynamic Susceptibility Contrast MRI in Glioblastoma Patients. Transl Oncol 2015; 8:137-46.

Who he is

Tracy Batchelor received his undergraduate and medical degrees from Emory University as well as graduate degrees from Harvard University. He completed training in internal medicine at Yale-New Haven Hospital, neurology at Massachusetts General Hospital and neuro-oncology at Memorial Sloan-Kettering Cancer Center. He served as the chief resident in neurology in his final year of residency training at Mass General.

He joined the professional staff at Mass General in 1996 and served as Director of the Neuro-Oncology Fellowship Training Program from 1996-2006. He has served as Executive Director of the Stephen E. and Catherine Pappas Center for Neuro-Oncology and Chief of the Division of Neuro-Oncology at Mass General Cancer Center since 2001.

What he does

He is currently a Professor of Neurology at Harvard Medical School. Dr. Batchelor’s research interests include the development of novel targeted therapeutics for glioblastomas and other primary tumors of the central nervous system. Dr. Batchelor’s main clinical interests include management of patients with primary tumors of the central nervous system including high-grade gliomas (glioblastoma, anaplastic astrocytoma, anaplastic oligodendroglioma, anaplastic ependymoma), low-grade gliomas (astrocytoma, oligodendroglioma, ependymoma), and primary CNS lymphomas.